Chefs' Warehouse, Inc.: Form 10-Q for the period ended Mar 29, 2024
Filed with the SEC on May 1, 2024 and accepted by EDGAR at May 1, 2024, 08:38 ET.
Management's discussion and analysis
As filed, 10,883 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided as a supplement to the accompanying condensed consolidated financial statements and footnotes to help provide an understanding of our financial condition, changes in our financial condition and results of operations. The following discussion should be read in conjunction with information included in our Annual Report on Form 10-K for the fiscal year ended December 29, 2023 (the “2023 Form 10-K”) filed with the Securities and Exchange Commission (“SEC”). Unless otherwise indicated, the terms “Company”, “Chefs’ Warehouse”, “we”, “us” and “our” refer to The Chefs’ Warehouse, Inc. and its subsidiaries.
Business Overview
We are a premier distributor of specialty foods in the leading culinary markets in the United States, the Middle East and Canada. We offer more than 70,000 stock-keeping units (“SKUs”), ranging from high-quality specialty foods and ingredients to basic ingredients and staples and center-of-the-plate proteins. We serve more than 44,000 core customer locations, primarily located in our 23 geographic markets across the United States, the Middle East and Canada, and the majority of our customers are independent restaurants and fine dining establishments. We also sell certain of our products directly to consumers through our Allen Brothers retail channel.
Acquisitions
On May 1, 2023, the Company entered into a stock purchase agreement to acquire substantially all of the equity interests of Oakville Produce Partners, LLC (“GreenLeaf”), a leading produce and specialty food distributor in Northern California. The final purchase price was $88.2 million consisting of $72.2 million paid in cash at closing, $3.5 million paid upon settlement of a net working capital true-up, the issuance of a $10.0 million unsecured note, and 75,008 shares of the Company’s common stock with an approximate value of $2.5 million based on the trading price of the Company’s common stock on the date of acquisition.
On March 20, 2023, pursuant to an asset purchase agreement, we acquired substantially all of the assets of Hardie’s F&V, LLC (“Hardie’s Fresh Foods”), a specialty produce distributor with operations in Texas. The final purchase price was approximately $41.4 million, consisting of $38.0 million paid in cash at closing, $0.6 million received upon settlement of a net working capital true-up, and an earn-out liability valued at approximately $4.0 million as of the acquisition date. If earned, the earn-out liability could total up to $10.0 million over a two-year period.
RESULTS OF OPERATIONS
| Thirteen Weeks Ended March 29, 2024 | March 31, 2023 | |
|---|---|---|
| Net sales | $874,488 | $719,645 |
| Cost of sales | 665,052 | 549,937 |
| Gross profit | 209,436 | 169,708 |
| Selling, general and administrative expenses | 190,321 | 156,137 |
| Other operating expenses, net | 3,112 | 1,672 |
| Operating income | 16,003 | 11,899 |
| Interest expense | 13,244 | 10,006 |
| Income before income taxes | 2,759 | 1,893 |
| Provision for income tax expense | 828 | 492 |
| Net income | $1,931 | $1,401 |
16
Thirteen Weeks Ended March 29, 2024 Compared to Thirteen Weeks Ended March 31, 2023
Net Sales
| 2024 | 2023 | $ Change | % Change | |
|---|---|---|---|---|
| Net sales | $874,488 | $719,645 | $154,843 | 21.5% |
Organic growth contributed $63.3 million, or 8.8%, to sales growth and the remaining sales growth of $91.5 million, or 12.7%, resulted from acquisitions. Organic case count increased approximately 4.6% in our specialty category. In addition, specialty unique customers and placements increased 10.1% and 12.0%, respectively, compared to the prior year period. Organic pounds sold in our center-of-the-plate category increased 6.2% compared to the prior year. Estimated inflation was 1.2% in our specialty category and 4.6% in our center-of-the-plate category compared to the prior year period.
Gross Profit
| 2024 | 2023 | $ Change | % Change | |
|---|---|---|---|---|
| Gross profit | $209,436 | $169,708 | $39,728 | 23.4% |
| Gross profit margin | 23.9% | 23.6% |
Gross profit dollars increased primarily as a result of increased sales and price inflation. Gross profit margin increased approximately 37 basis points. Gross profit margins decreased 4 basis points in the Company’s specialty category and increased 18 basis points in the Company’s center-of-the-plate category.
Selling, General and Administrative Expenses
| 2024 | 2023 | $ Change | % Change | |
|---|---|---|---|---|
| Selling, general and administrative expenses | $190,321 | $156,137 | $34,184 | 21.9% |
| Percentage of net sales | 21.8% | 21.7% |
The increase in selling, general and administrative expenses was primarily due to higher depreciation and amortization driven by acquisitions and facility investments, and higher costs associated with compensation and benefits, facilities and distribution to support sales growth. Our ratio of selling, general and administrative expenses to net sales increased 10 basis points due to increased near-term costs associated with our investments in facilities and acquisitions.
Other Operating Expenses, Net
| 2024 | 2023 | $ Change | % Change | |
|---|---|---|---|---|
| Other operating expenses, net | $3,112 | $1,672 | $1,440 | 86.1% |
Other operating expenses increased by $1.4 million primarily due to charges associated with employee severance in the first quarter of 2024.
Interest Expense
| 2024 | 2023 | $ Change | % Change | |
|---|---|---|---|---|
| Interest expense | $13,244 | $10,006 | $3,238 | 32.4% |
Interest expense increased primarily driven by higher principal amounts of outstanding debt and higher rates of interest charged on the variable rate portion of our outstanding debt.
Provision for Income Tax Expense
| 2024 | 2023 | $ Change | % Change | |
|---|---|---|---|---|
| Provision for income tax expense | $828 | $492 | $336 | 68.3% |
| Effective tax rate | 30.0% | 26.0% |
The higher effective tax rate for the thirteen weeks ended March 29, 2024 was primarily driven by the non-deductibility of certain compensation related items.
LIQUIDITY AND CAPITAL RESOURCES
We finance our day-to-day operations and growth primarily with cash flows from operations, borrowings under our senior secured credit facilities and other indebtedness, operating leases, trade payables and equity financing.
Indebtedness
The following table presents selected financial information on our indebtedness (in thousands):
| March 29, 2024 | December 29, 2023 | |
|---|---|---|
| Senior secured term loan | $269,500 | $276,250 |
| Total convertible debt | 327,184 | 327,184 |
| Borrowings outstanding on asset-based loan facility | 100,000 | 100,000 |
| Finance leases and other financing obligations | 42,121 | 31,892 |
Recent Financing Transactions
In March 2024, we amended our senior secured term loan agreement, which reduced the interest rate spread by 75 basis points on our senior secured term loan B facility. Additionally, during the thirteen weeks ended March 29, 2024, we made voluntary principal prepayments of $6.0 million towards the senior secured term loan.
In November 2023, we announced a two-year share repurchase program in an amount up to $100,000, targeting $25.0 million to $100.0 million of share repurchases by the end of fiscal 2025. During the thirteen weeks ended March 29, 2024, we repurchased 134,553 shares of our common stock at an average purchase price of $37.16 per share. The share repurchases were funded by our available cash. The remaining share purchase authorization was $95,000 at March 29, 2024. We are not obligated to repurchase any specific number of shares and may suspend or discontinue the program at any time.
Liquidity
The following table presents selected financial information on liquidity (in thousands):
| March 29, 2024 | December 29, 2023 | |
|---|---|---|
| Cash and cash equivalents | $42,266 | $49,878 |
| Working capital(1), excluding cash and cash equivalents | 290,555 | 295,288 |
| Availability under asset-based loan facility | 162,064 | 172,030 |
(1) We define working capital as current assets less current liabilities.
We expect our capital expenditures, excluding cash paid for acquisitions, for fiscal 2024 will be approximately $35.0 million to $45.0 million. We believe our existing balances of cash and cash equivalents, working capital and the availability under our asset-based loan facility, are sufficient to satisfy our working capital needs, capital expenditures, debt service and other liquidity requirements associated with our current operations over the next twelve months.
Cash Flows
The following table presents selected financial information on cash flows (in thousands):
| Thirteen Weeks Ended March 29, 2024 | March 31, 2023 | |
|---|---|---|
| Net cash provided by (used in) operating activities | $30,900 | $(2,261) |
| Net cash used in investing activities | $(17,381) | $(59,633) |
| Net cash used in financing activities | $(21,252) | $(5,141) |
Our cash provided by operating activities is predominately driven by net sales to our customers. Our cash used in operating activities is primarily driven by our payments to suppliers for our inventory, employee compensation, payments to support our facilities, our distribution network, interest on our indebtedness, payments to tax authorities and other general corporate expenditures. Net cash provided by operations was $30.9 million for the thirteen weeks ended March 29, 2024 compared to cash used in operating activities of $2.3 million for the thirteen weeks ended March 31, 2023. The increase in cash provided by operating activities was primarily due to lower inventory purchase levels in the current period as the prior year results included a strategic pull forward of inventory purchases that did not recur.
Net cash used in investing activities was $17.4 million for the thirteen weeks ended March 29, 2024, driven by capital expenditures of $17.1 million.
Net cash used in financing activities was $21.3 million for the thirteen weeks ended March 29, 2024 driven by $6.8 million of payments of debt and other financing obligations, $5.0 million used to repurchase our common stock, $7.1 million paid for shares surrendered to pay tax withholding related to the vesting of equity incentive plan awards, $1.3 million of earn-out payments and $1.1 million of finance lease payments.
Recent Accounting Pronouncements
Information related to new accounting guidance is included in Note 1 “Operations and Basis of Presentation” to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Market risk
As filed, 389 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Interest Rate Risk
Our exposure to interest rate market risk relates primarily to our long-term debt. As of March 29, 2024, we had aggregate indebtedness outstanding of $369.5 million that bore interest at variable rates. A 100 basis point increase in market interest rates would decrease our after-tax earnings by approximately $2.6 million per annum, holding other variables constant.
Controls and procedures
As filed, 1,272 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of March 29, 2024.
Changes in Internal Control over Financial Reporting
There were no changes in our internal controls over financial reporting that occurred during the quarter ended March 29, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. The Company is actively integrating the Hardie’s and GreenLeaf acquisitions into its overall system of internal control over financial reporting and, if necessary, will make appropriate changes as it integrates Hardie’s and GreenLeaf into the Company's overall internal control over financial reporting process.
Risk factors
As filed, 311 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to our risk factors as previously disclosed in Part I, Item 1A. included in our Annual Report on Form 10-K for the year ended December 29, 2023. In addition to the information contained herein, you should consider the risk factors disclosed in our Annual Report on Form 10-K.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-12-30 to 2024-03-29 | $874.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-12-30 to 2024-03-29 | $665.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-12-30 to 2024-03-29 | $209.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-12-30 to 2024-03-29 | $190.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-12-30 to 2024-03-29 | $16.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-12-30 to 2024-03-29 | $13.2m | us-gaap:InterestExpense |
| Income tax | 3 months2023-12-30 to 2024-03-29 | $828.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-12-30 to 2024-03-29 | $1.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-12-30 to 2024-03-29 | $0.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-12-30 to 2024-03-29 | $0.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-12-30 to 2024-03-29 | 38,626,885 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-12-30 to 2024-03-29 | $30.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-12-30 to 2024-03-29 | $17.1m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 3 months2023-12-30 to 2024-03-29 | $5.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-29 | $42.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-29 | $692.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-29 | $1.67bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-29 | $359.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-29 | $1.22bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-29 | $667.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-29 | $55.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-03-29 | $447.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001517175-24-000011. Last ingested by Listed: Nov 15, 2026, 01:17 ET. Listed shows no prices and gives no investment advice.